Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Molybdenum trioxide (MoO3) is an inorganic compound with widespread industrial applications, including its use as a catalyst, in metallurgy, and in organic electronic devices due to its high work function and favorable energy level alignment. Beyond its industrial utility, it is actively investigated for diverse therapeutic applications. These include its role as a crucial micronutrient in dietary supplements, where it supports essential enzymatic functions and aids detoxification. In nanostructured forms, molybdenum trioxide exhibits antimicrobial activity by generating H+ ions and activating membrane stress in pathogens, and shows promise in cancer therapeutics through mechanisms such like photothermal effects, reactive oxygen species (ROS) production, pyroelectric field generation, and induction of mitochondrial-mediated apoptosis. It also contributes to enhanced wound healing and is explored for advanced photonic and sensing applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Molybdenum trioxide.